{"schemaVersion":"ready-scan.discovery-surface.v1","id":"urn:readyscan:corpus:buyer-question:veristat-q131986594-answer-34458a603e1bff48200e","key":"buyer_question:veristat-q131986594-answer-34458a603e1bff48200e","kind":"buyer_question","slug":"veristat-q131986594-answer-34458a603e1bff48200e","canonicalUrl":"https://readyscan.ai/corpus/buyer-question/veristat-q131986594-answer-34458a603e1bff48200e","machineUrl":"https://readyscan.ai/discovery/corpus/buyer-question/veristat-q131986594-answer-34458a603e1bff48200e.json","datePublished":"2026-10-25","dateModified":"2026-10-25","materialFingerprint":"fnv1a64:ea254a37b9187c16","membershipFingerprint":"fnv1a64:85a7c038071c850f","relatedEntitySlugs":["veristat-q131986594"],"relatedSurfaceKeys":["buyer_question:veristat-q131986594-answer-1a02751483e69f2ab788","buyer_question:veristat-q131986594-answer-3412882f879455f677e8","buyer_question:veristat-q131986594-answer-39b32ed129c8622469be","buyer_question:veristat-q131986594-answer-518eadbfcb69743d223e","buyer_question:veristat-q131986594-answer-5fbc154d4b1ba432fb13","buyer_question:veristat-q131986594-answer-6212fedf973f6b93dd9b","buyer_question:veristat-q131986594-answer-68df9892211ef7060c6a","buyer_question:veristat-q131986594-answer-aa510bdb0ccf031ed5bb","buyer_question:veristat-q131986594-answer-c4405cf9ec71555384b3","buyer_question:veristat-q131986594-answer-cfd6628316e7e985c4b7","buyer_question:veristat-q131986594-answer-fe587a9c2de404de4138","evidence:veristat-q131986594"],"sourceIds":["ready-scan-subjects"],"provenance":[{"snapshotId":"veristat-q131986594-content-20eafb8411341c3d-snapshot","sourceId":"ready-scan-subjects","sourceRecordId":"Q131986594","sourceRevisionId":"Q131986594:content:b79eadc27cef7bcc","sourceContentHash":"fnv1a64:1dce5caf659418af","recordRevisionId":"Q131986594:content:b79eadc27cef7bcc","recordContentHash":"fnv1a64:b2a53c98a2b6b9ea","sourceCanonicalUrl":"https://www.veristat.com/","sourceModifiedAt":"2026-10-25T07:29:48.087Z","observedOn":"2026-10-25","permission":{"basis":"public_information","evidenceUrl":"https://www.veristat.com/"},"attributionUrl":"https://www.veristat.com/"}],"quality":{"method":"same_kind_unique_trigram_floor","minimumUniqueTrigramRatio":0.3,"status":"passed"},"title":"What does a regulatory gap analysis identify for a MD or IVD program?","summary":"Cited source answers across 1 active corpus record.","question":"What does a regulatory gap analysis identify for a MD or IVD program?","answers":[{"entitySlug":"veristat-q131986594","entityName":"Veristat","answer":"“A regulatory Gap Analysis identifies the difference between a device's current state of development and what's required for certification, helping define the objectives and milestones needed to reach the next goal, whether that's entering clinical stage, completing clinical evaluation, or obtaining the CE mark.”","sourceUrls":["https://www.veristat.com/regulatory-expertise-for-mds-ivds-and-cdx"]}]}